Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: a prospective study

Sergey Spektor, Samuel Agus, Vladimir Merkin, +1

Journal of neurosurgery

A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage

Yuval Ishay, Assaf Potruch, Asaf Schwartz, +4

Biomedicine & Pharmacotherapy

The Patient Experience with DSM-5-Defined Binge Eating Disorder: Characteristics, Barriers to Treatment, and Implications for Primary Care Physicians

Barry K. Herman, Shima Safikhani, David Hengerer, +6

Postgraduate Medicine

A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial

Ram Gelman, Noa Hurvitz, Rima Nesserat, +8

Biomedicine & Pharmacotherapy

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, +48

EClinicalMedicine

A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

Noa Hurvitz, Tama Dinur, Shoshana Revel‐Vilk, +4

Journal of Clinical Medicine

Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial

Tal Sigawi, Ram Gelman, Ofra Maimon, +6

Frontiers in Oncology